Akaishi Tetsuya, Tarasawa Kunio, Hamada Hirotaka, Iwama Noriyuki, Tomita Hasumi, Akaishi Miho, Fushimi Kiyohide, Fujimori Kenji, Yaegashi Nobuo, Saito Masatoshi
Department of Education and Support for Regional Medicine, Tohoku University Hospital, Sendai, Japan.
Department of Health Administration and Policy, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hypertens Res. 2024 Feb;47(2):455-466. doi: 10.1038/s41440-023-01511-8. Epub 2023 Nov 22.
Critical bleeding is a common cause of maternal mortality in obstetric patients. However, the non-obstetric factors underlying critical obstetric bleeding remain uncertain. Therefore, this study aimed to clarify the impact of chronic hypertension on obstetric hemorrhage by evaluating a nationwide administrative database in Japan. Women who gave birth between 2018 and 2022 were enrolled. The primary outcome was critical hemorrhage requiring massive red blood cell (RBC) transfusion during childbirth. In total, 354, 299 eligible women were selected from the database. The maternal mortality rate was >1.0% among those who received a massive RBC transfusion (≥4000 cc), and this amount was used as the cutoff of the outcome. Critical hemorrhage was less frequent with elective Caesarean section (CS) compared with vaginal childbirth or emergent CS (odds ratio [OR], 0.38; 95% confidence interval, 0.30-0.47). Multiple logistic regression analysis adjusting for these obstetric risks revealed that a higher maternal age (adjusted OR [aOR] per 1 year, 1.07 [1.05-1.09]); oral medications with prednisolone (aOR, 2.5 [1.4-4.4]), anti-coagulants (aOR, 10 [5.4-19]), and anti-platelets (aOR, 2.9 [1.3-6.4]); and a prenatal history of hypertension (aOR, 2.5 [1.5-4.4]) and hypoproteinemia (aOR, 5.8 [1.7-20]) are the risks underlying critical obstetric hemorrhage. Prenatal history of hypertension was significantly associated with obstetric disseminated intravascular coagulation (OR, 1.9 [1.5-2.4]); Hemolysis, Elevated Liver enzymes, and Low platelet count (HELLP) syndrome (OR, 3.3 [2.7-4.2]); and eclampsia (OR, 6.1 [4.6-8.1]). In conclusion, a maternal prenatal history of hypertension is associated with the development of HELLP syndrome, eclampsia, and resultant critical hemorrhage. The incidence of HELLP syndrome and eclampsia increased more than fivefold in the presence of prenatal hypertension. However, the likelihood of subsequently developing DIC or experiencing critical bleeding did not change by the presence of prenatal hypertension.
严重出血是产科患者孕产妇死亡的常见原因。然而,产科严重出血背后的非产科因素仍不明确。因此,本研究旨在通过评估日本全国性行政数据库来阐明慢性高血压对产科出血的影响。纳入了2018年至2022年间分娩的女性。主要结局是分娩期间需要大量输注红细胞(RBC)的严重出血。总共从数据库中选取了354299名符合条件的女性。接受大量RBC输注(≥4000 cc)的女性中孕产妇死亡率>1.0%,这一输注量被用作结局的临界值。与阴道分娩或急诊剖宫产相比,择期剖宫产时严重出血的发生率较低(优势比[OR],0.38;95%置信区间,0.30 - 0.47)。对这些产科风险进行校正的多因素逻辑回归分析显示,孕产妇年龄较大(每增加1岁校正OR[aOR],1.07[1.05 - 1.09]);使用泼尼松龙口服药物(aOR,2.5[1.4 - 4.4])、抗凝剂(aOR,10[5.4 - 19])和抗血小板药物(aOR,2.9[1.3 - 6.4]);以及产前有高血压病史(aOR,2.5[1.5 - 4.4])和低蛋白血症(aOR,5.8[1.7 - 20])是产科严重出血的潜在风险因素。产前高血压病史与产科弥散性血管内凝血显著相关(OR,1.9[1.5 - 2.4]);溶血、肝酶升高和血小板减少(HELLP)综合征(OR,3.3[2.7 - 4.2]);以及子痫(OR,6.1[4.6 - 8.1])。总之,孕产妇产前高血压病史与HELLP综合征、子痫及由此导致的严重出血的发生有关。在产前高血压存在的情况下,HELLP综合征和子痫的发生率增加了五倍多。然而,产前高血压的存在并未改变随后发生弥散性血管内凝血或严重出血的可能性。